| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -4.49 | -2.21 | -1.13 | -961.92 |
| Net Changein Cash | -230.35 | 17.59 | -228.33 | 396.56 |
| Cash Taxes Paid | 162.95 | 162.96 | 153.57 | 138.17 |
| Net Income/ Starting Line | 654.13 | 631.29 | 628.61 | 564.93 |
| Changesin Working Capital | -343.33 | -297.04 | -367.23 | -38.33 |
| Cashfrom Operating Activities | 391.52 | 413.52 | 306.01 | 597.59 |
| Cash Interest Paid | 2.41 | 1.55 | 0.55 | 0.07 |
| Cashfrom Financing Activities | -6.23 | -279.44 | -387.59 | -78.80 |
| Issuance( Retirement)of Stock Net | 0.67 | - | - | 1,011.85 |
| Depreciation/ Depletion | 60.61 | 53.45 | 42.09 | 37.88 |
| Other Investing Cash Flow Items Total | -449.46 | 12.49 | 16.05 | 9.94 |
| Capital Expenditures | -166.19 | -128.97 | -162.80 | -132.17 |
| period Type | - | - | - | - |
| Non- Cash Items | 20.11 | 25.82 | 2.53 | 33.11 |
| Financing Cash Flow Items | -2.41 | -1.55 | -0.55 | -0.07 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -615.65 | -116.48 | -146.75 | -122.23 |
| Total Cash Dividends Paid | - | -275.69 | -385.92 | -128.65 |
Alivus Life Sciences Dividend Alivus Life Sciences Bonus Alivus Life Sciences News Alivus Life Sciences AGM Alivus Life Sciences Rights Alivus Life Sciences Splits Alivus Life Sciences Board Meetings Alivus Life Sciences Key Metrics Alivus Life Sciences Shareholdings Alivus Life Sciences Profit Loss Alivus Life Sciences Balance Sheet Alivus Life Sciences Q1 Results Alivus Life Sciences Q2 Results Alivus Life Sciences Q3 Results Alivus Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks